Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis

Clinical trial NCT06031389 · UNKNOWN

Trial details

NCT number: NCT06031389
Sponsor: Qianfoshan Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetic Nephropathies

Start date: 2024-01-01
Primary completion: 2024-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.